Efficacy and Safety of Tislelizumab Plus Chemotherapy as Conversion Therapy in Unresectable Locally Advanced ESCC

​ Conditions: Locally Advanced Esophageal Squamous Cell Carcinoma

Interventions: Drug: Tislelizumab Plus Chemotherapy

Sponsors: Shandong Provincial Hospital

Recruiting Conditions: Locally Advanced Esophageal Squamous Cell Carcinoma
Interventions: Drug: Tislelizumab Plus Chemotherapy
Sponsors: Shandong Provincial Hospital
Recruiting